Stock Taper
Medpace Holdings, Inc. provides comprehensive clinical research services across all phases for pharma, biotech, and medical device industries worldwide, including development, regulatory, data management, and laboratory support.

Medpace is a global CRO offering comprehensive clinical development services from Phase I to IV, including study design, patient recruitment, regulatory submissions, and data management for biotech, pharma, and medical device companies.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Metabolic | $199.26M | $249.81M ▲ | $237.56M ▼ | $219.07M ▼ |
![]() | Oncology | $192.63M | $195.92M ▲ | $201.24M ▲ | $209.37M ▲ |
![]() | Other | $106.4M | $88.25M ▼ | $93.32M ▲ | $98.28M ▲ |
![]() | Central Nervous System | $65.63M | $73.18M ▲ | $80.21M ▲ | $82.86M ▲ |
![]() | Cardiology | $59.47M | $63.04M ▲ | $56.26M ▼ | $59.98M ▲ |
![]() | Antiviral And Anti Infective | $36.52M | $38.25M ▲ | $38.02M ▼ | $37.77M ▼ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
CNC | $68.03 | COMPARE |
ILMN | $215.99 | COMPARE |
WAT | $411.90 | COMPARE |
DGX | $237.28 | COMPARE |
WST | $341.98 | COMPARE |
THC | $263.89 | COMPARE |
ICLR | $162.21 | COMPARE |
SNN | $28.66 | COMPARE |